Group One Trading’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-108
| Closed | -$3.55K | – | 7632 |
|
|
2024
Q1 | $3.55K | Hold |
108
| – | – | ﹤0.01% | 6320 |
|
|
2023
Q4 | $2.9K | Sell |
108
-259
| -71% | -$10.7K | ﹤0.01% | 6709 |
|
|
2023
Q3 | $22.2K | Buy |
367
+256
| +231% | +$24K | ﹤0.01% | 5813 |
|
|
2023
Q2 | $11.3K | Buy |
111
+11
| +11% | +$1.51K | ﹤0.01% | 6330 |
|
|
2023
Q1 | $17.7K | Buy |
+100
| New | +$33.5K | ﹤0.01% | 5592 |
|
|
2022
Q4 | – | Sell |
-36
| Closed | -$12K | – | 8247 |
|
|
2022
Q3 | $12K | Sell |
36
-456
| -93% | -$165K | ﹤0.01% | 6395 |
|
|
2022
Q2 | $162K | Sell |
492
-8
| -2% | -$2.81K | ﹤0.01% | 4507 |
|
|
2022
Q1 | $219K | Sell |
500
-381
| -43% | -$156K | ﹤0.01% | 4709 |
|
|
2021
Q4 | $386K | Sell |
881
-672
| -43% | -$338K | ﹤0.01% | 4410 |
|
|
2021
Q3 | $864K | Buy |
1,553
+836
| +117% | +$419K | ﹤0.01% | 3581 |
|
|
2021
Q2 | $368K | Sell |
717
-100
| -12% | -$63.4K | ﹤0.01% | 4561 |
|
|
2021
Q1 | $638K | Sell |
817
-877
| -52% | -$600K | ﹤0.01% | 3751 |
|
|
2020
Q4 | $923K | Hold |
1,694
| – | – | ﹤0.01% | 2712 |
|
|
2020
Q3 | $776K | Sell |
1,694
-414
| -20% | -$240K | ﹤0.01% | 2428 |
|
|
2020
Q2 | $1.3M | Buy |
2,108
+14
| +0.7% | +$7.73K | 0.01% | 1802 |
|
|
2020
Q1 | $996K | Sell |
2,094
-2,706
| -56% | -$1.47M | 0.01% | 1525 |
|
|
2019
Q4 | $2.78M | Buy |
4,800
+2,214
| +86% | +$1.55M | 0.02% | 1030 |
|
|
2019
Q3 | $1.7M | Sell |
2,586
-1,031
| -29% | -$857K | 0.01% | 1337 |
|
|
2019
Q2 | $2.8M | Buy |
3,617
+1,873
| +107% | +$1.32M | 0.03% | 859 |
|
|
2019
Q1 | $1.23M | Buy |
1,744
+97
| +6% | +$58.1K | 0.01% | 1266 |
|
|
2018
Q4 | $771K | Sell |
1,647
-150
| -8% | -$96.8K | 0.01% | 1697 |
|
|
2018
Q3 | $1.55M | Sell |
1,797
-3,106
| -63% | -$2.24M | 0.01% | 1346 |
|
|
2018
Q2 | $3.38M | Buy |
4,903
+4,506
| +1,135% | +$2.29M | 0.03% | 757 |
|
|
2018
Q1 | $177K | Sell |
397
-497
| -56% | -$241K | ﹤0.01% | 2876 |
|
|
2017
Q4 | $394K | Sell |
894
-1,459
| -62% | -$665K | ﹤0.01% | 2449 |
|
|
2017
Q3 | $1.16M | Sell |
2,353
-5,228
| -69% | -$2.62M | 0.01% | 1445 |
|
|
2017
Q2 | $4.2M | Buy |
7,581
+6,881
| +983% | +$4.37M | 0.04% | 538 |
|
|
2017
Q1 | $463K | Buy |
700
+614
| +714% | +$328K | 0.01% | 1896 |
|
|
2016
Q4 | $29K | Buy |
86
+83
| +2,767% | +$26.6K | ﹤0.01% | 3550 |
|
|
2016
Q3 | $1K | Sell |
3
-389
| -99% | -$84.3K | ﹤0.01% | 4459 |
|
|
2016
Q2 | $68K | Buy |
392
+281
| +253% | +$61.2K | ﹤0.01% | 3113 |
|
|
2016
Q1 | $25K | Buy |
+111
| New | +$33.2K | ﹤0.01% | 3641 |
|
|
2015
Q4 | – | Sell |
-75
| Closed | -$39K | – | 5170 |
|
|
2015
Q3 | $39K | Buy |
+75
| New | +$50.2K | ﹤0.01% | 3682 |
|
Other funds holding TVRD
SPC
VCM
AFG
SAM
DWAM
Group One Trading's TVRD Position: Q1 2026 in Review
Group One Trading increased its Tvardi Therapeutics (TVRD) stake by 88% in Q1 2026, buying an estimated $392 and bringing the position to 214 shares worth $681. The position accounts for ﹤0.01% of the portfolio, ranked #7278.
Group One Trading first reported a position in TVRD in Q2 2015 and has held it in 33 quarters since. The position peaked at $1.77M in Q4 2019. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.
- Group One Trading held 214 shares of Tvardi Therapeutics worth $681 as of Q1 2026.
- Group One Trading bought 100 Tvardi Therapeutics shares in Q1 2026, an estimated $392.
- Tvardi Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7278 holding.
- Group One Trading first reported a position in Tvardi Therapeutics in Q2 2015 and has held it in 33 quarters since.
- Group One Trading's Tvardi Therapeutics position peaked at $1.77M in Q4 2019.
- 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.